<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02647957</url>
  </required_header>
  <id_info>
    <org_study_id>489/2015</org_study_id>
    <nct_id>NCT02647957</nct_id>
  </id_info>
  <brief_title>A Study of the Efficacy of the Code Stroke in Spain</brief_title>
  <acronym>QICS</acronym>
  <official_title>Indicators for Quality Assessment of Hospitalized Ischemic Stroke Patients. A Study of the Efficacy of the Code Stroke in Spain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Miguel Hernandez de Elche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Serranía de Ronda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario de Navarra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Virgen de la Concha</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Complejo Hospitalario de Jaén</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital General San Jorge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Miguel Hernandez de Elche</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Code Stroke is a system for the rapid identification, pre-notification and transport of acute
      ischemic stroke patients. The objective of this study was to define quality indicators and to
      compare treatment outcomes in hospitals where Code Stroke has been implemented and hospitals
      without the use of Code Stroke (control patients).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a first step qualitative technique has been conducted to define treatment quality
      indicators of acute ischemic stroke patients. In a second step a prospective study is
      conducted to collect data of 240 inpatients from two groups of hospitals. Two hospitals
      applying Code Stroke (N= 120) and four hospitals non-applying Code Stroke procedure (N=120).
      A consecutive sampling method will be conducted. Inclusion criteria: acute ischemic stroke
      patients treated in the hospitals during the field study. The referral to the hospital could
      be from primary care, Emergency Unit of other hospital. Patients will enroll after inform
      consent.

      A Singer-blind- research method will applied. Quality indicators defined in the first phase
      will be applied and comparisons will be realized using ANOVA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery rate of the Intravenous trombolysis treatment</measure>
    <time_frame>1 month</time_frame>
    <description>Number of patients showing an adequate recovery after Intravenous trombolysis treatment as assessed by the criteria of the Quality Indicator Board of the German Stroke Registers Study Group and the National Sentinel Audit of Stroke.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1 month</time_frame>
    <description>Patient Satisfaction Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient engage</measure>
    <time_frame>1 month</time_frame>
    <description>Health literacy Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>response capacity</measure>
    <time_frame>1 day</time_frame>
    <description>Response time for the initial evaluation and treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment adequacy: Intravenous trombolysis treatment</measure>
    <time_frame>1 month</time_frame>
    <description>Intravenous trombolysis treatment applied in eligible ischemic stroke patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient safety. Complications in the recombinant tissue plasminogen activator treatment after tromobysis</measure>
    <time_frame>1 month</time_frame>
    <description>Recombinant tissue plasminogen activator complication rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rates of the Intravenous trombolysis treatment</measure>
    <time_frame>1 month</time_frame>
    <description>Mortality rates of the Intravenous trombolysis treatment when applied in eligible ischemic stroke patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hospital using Code Stroke</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Hospital not using Code Stroke</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Code Stroke</intervention_name>
    <description>Apply a protocol called Code Stroke that involves the entire care chain from emergency teams outpatient specialists of Neurology, Internal Medicine, Radiology or Intensitivos Care, among other hospital areas.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute ischemic stroke in-patients

        Exclusion Criteria:

          -  Patients who refuse participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Alvarez Sabín J, Molina C, Abilleira S, Montaner J, García F, Alijotas J. [&quot;Stroke code&quot;. Shortening the delay in reperfusion treatment of acute ischemic stroke]. Med Clin (Barc). 1999 Oct 23;113(13):481-3. Spanish.</citation>
    <PMID>10604170</PMID>
  </results_reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2015</study_first_submitted>
  <study_first_submitted_qc>January 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2016</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Miguel Hernandez de Elche</investigator_affiliation>
    <investigator_full_name>José Joaquín Mira</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>acute ischemic stroke</keyword>
  <keyword>quality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

